Literature DB >> 18566329

Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells.

Kumudha Balakrishnan1, William G Wierda, Michael J Keating, Varsha Gandhi.   

Abstract

Gossypol, a cottonseed extract derivative, acts as a BH3-mimetic, binding to the BH3 pocket of antiapoptotic proteins and displacing pro-death partners to induce apoptosis. However, knowledge on the molecular underpinnings of its downstream effects is limited. Since chronic lymphocytic leukemia (CLL) cells express high levels of antiapoptotic proteins that act as a survival mechanism for these replicationally quiescent lymphocytes, we investigated whether gossypol induces apoptosis in these cells and what mechanism underlies gossypol-mediated cytotoxicity. Gossypol induced cell death in a concentration- and time-dependent manner; 24-hour incubation with 30 microM gossypol resulted in 50% cell death (median; range, 10%-80%; n = 47) that was not abrogated by pan-specific caspase inhibitor. Starting at 4 hours, the mitochondrial outer membrane was significantly permeabilized (median, 77%; range, 54%-93%; n = 15). Mitochondrial outer membrane permeabiliztaion (MOMP) was concurrent with increased production of reactive oxygen species (ROS); however, antioxidants did not abrogate gossypol-induced cell death. Mitochondrial membrane permeabilization was also associated with loss of intracellular adenosine triphosphate (ATP), activation of BAX, and release of cytochrome c and apoptosis-inducing factor (AIF), which was translocated to the nucleus. Blocking AIF translocation resulted in a decreased apoptosis, suggesting that AIF contributes to gossypol-mediated cytotoxicity in CLL lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566329      PMCID: PMC2518898          DOI: 10.1182/blood-2007-12-126946

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  66 in total

Review 1.  Mitochondria: releasing power for life and unleashing the machineries of death.

Authors:  Donald D Newmeyer; Shelagh Ferguson-Miller
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

Review 2.  Chemotherapy: targeting the mitochondrial cell death pathway.

Authors:  Klaus-Michael Debatin; Delphine Poncet; Guido Kroemer
Journal:  Oncogene       Date:  2002-12-12       Impact factor: 9.867

3.  Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins.

Authors:  Shinichi Kitada; Marilisa Leone; Sina Sareth; Dayong Zhai; John C Reed; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2003-09-25       Impact factor: 7.446

Review 4.  Guardians of cell death: the Bcl-2 family proteins.

Authors:  Peter T Daniel; Klaus Schulze-Osthoff; Claus Belka; Dilek Güner
Journal:  Essays Biochem       Date:  2003       Impact factor: 8.000

5.  (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.

Authors:  Liang Xu; Dajun Yang; Shaomeng Wang; Wenhua Tang; Meilan Liu; Mary Davis; Jianyong Chen; James M Rae; Theodore Lawrence; Marc E Lippman
Journal:  Mol Cancer Ther       Date:  2005-02       Impact factor: 6.261

6.  (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance.

Authors:  Christopher L Oliver; Michelle B Miranda; Sanjeev Shangary; Stephanie Land; Shaomeng Wang; Daniel E Johnson
Journal:  Mol Cancer Ther       Date:  2005-01       Impact factor: 6.261

7.  Synthesis of gossypol atropisomers and derivatives and evaluation of their anti-proliferative and anti-oxidant activity.

Authors:  Kalliopi Dodou; Rosaleen J Anderson; W John Lough; David A P Small; Michael D Shelley; Paul W Groundwater
Journal:  Bioorg Med Chem       Date:  2005-07-01       Impact factor: 3.641

8.  Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells.

Authors:  Manchao Zhang; Hongpeng Liu; Ribo Guo; Yan Ling; Xiaojin Wu; Bihua Li; Peter P Roller; Shaomeng Wang; Dajun Yang
Journal:  Biochem Pharmacol       Date:  2003-07-01       Impact factor: 5.858

Review 9.  Bax, reactive oxygen, and cytochrome c release in neuronal apoptosis.

Authors:  Rebecca A Kirkland; James L Franklin
Journal:  Antioxid Redox Signal       Date:  2003-10       Impact factor: 8.401

10.  Translocation of apoptosis-inducing factor in vulnerable neurons after transient cerebral ischemia and in neuronal cultures after oxygen-glucose deprivation.

Authors:  Guodong Cao; Robert S B Clark; Wei Pei; Wei Yin; Feng Zhang; Feng-Yan Sun; Steven H Graham; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2003-10       Impact factor: 6.200

View more
  37 in total

1.  The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy.

Authors:  Yue Wei; Tapan Kadia; Weigang Tong; Ming Zhang; Yu Jia; Hui Yang; Yumin Hu; Francesco Paolo Tambaro; Jean Viallet; Susan O'Brien; Guillermo Garcia-Manero
Journal:  Clin Cancer Res       Date:  2010-06-10       Impact factor: 12.531

2.  Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma.

Authors:  Wei-Gang Tong; Rong Chen; William Plunkett; David Siegel; Rajni Sinha; R Donald Harvey; Ashraf Z Badros; Leslie Popplewell; Steven Coutre; Judith A Fox; Kristi Mahadocon; Tianling Chen; Peggy Kegley; Ute Hoch; William G Wierda
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

3.  AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance.

Authors:  Kumudha Balakrishnan; Jan A Burger; William G Wierda; Varsha Gandhi
Journal:  Blood       Date:  2008-10-03       Impact factor: 22.113

4.  (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.

Authors:  Xiufeng Pang; Yuanyuan Wu; Yougen Wu; Binbin Lu; Jing Chen; Jieqiong Wang; Zhengfang Yi; Weijing Qu; Mingyao Liu
Journal:  Mol Cancer Ther       Date:  2011-03-03       Impact factor: 6.261

Review 5.  Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy.

Authors:  S Fulda; D Kögel
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

6.  The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells.

Authors:  Ping Gao; Chantal Bauvy; Sylvie Souquère; Giovanni Tonelli; Lei Liu; Yushan Zhu; Zhenzhen Qiao; Daniela Bakula; Tassula Proikas-Cezanne; Gérard Pierron; Patrice Codogno; Quan Chen; Maryam Mehrpour
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 7.  Bcl-2 antagonists: a proof of concept for CLL therapy.

Authors:  Kumudha Balakrishnan; Varsha Gandhi
Journal:  Invest New Drugs       Date:  2013-08-02       Impact factor: 3.850

8.  Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.

Authors:  Rong Chen; William G Wierda; Sherri Chubb; Rachael E Hawtin; Judith A Fox; Michael J Keating; Varsha Gandhi; William Plunkett
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

Review 9.  Targeting the apoptosis pathway in hematologic malignancies.

Authors:  Shadia Zaman; Rui Wang; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2014-02-04

10.  ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway.

Authors:  Zhe-Yu Hu; Jian Sun; Xiao-Feng Zhu; Dajun Yang; Yi-Xin Zeng
Journal:  J Transl Med       Date:  2009-08-23       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.